At Synbio Technologies, we are at the forefront of synthetic biology innovation, empowering scientists and researchers to explore the complex world of genetics and biological functions with cutting-edge technology. Our high-throughput sequencing technology has revolutionized the study of transcriptomes, allowing us to comprehensively sequence almost all RNA information in a tissue or organ.
Transcriptomes are critical to understanding the genetic makeup of a particular cell under a specific physiological condition. By analyzing mRNA, rRNA, tRNA, and non-coding RNA, we can gain insights into the expression of genes in cells, tissues, or individuals under different physiological or pathological conditions. This knowledge forms the foundation of genetic research, clinical diagnosis, and drug development.
At Synbio Technologies, we are proud to offer eukaryotic and prokaryotic RNA sequencing services that enable researchers to unlock the full potential of transcriptomes. By harnessing the power of RNA sequencing, we can bond a genome’s genetic information with biological functions, enabling us to develop a deeper understanding of the intricate mechanisms that drive life.
The design idea of a transcriptome experiment is to compare different genes, and the common type is to compare the experimental group and the control group. With time and space factors considered, multiple comparative analyses can be implemented according to different growth stages or the occurrence and development of diseases. At least 3 biological replicates are required for each group.
1. Prokaryotic transcriptome sequencing
2. Eukaryotic transcriptome sequencing with reference genome
3. Eukaryotic transcriptome sequencing without reference genome